This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Failure of BQ123, a more potent antagonist of sarafotoxin 6b than of endothelin-1, to distinguish between these agonists in binding experiments, British Journal of Pharmacology, May 1996, Wiley,
DOI: 10.1111/j.1476-5381.1996.tb15407.x.
You can read the full text:
The following have contributed to this page
